Fresenius Kabi USA has announced the availability of 10 ml vials of 20% acetylcysteine inhalation solution. Acetylcysteine inhalation solution has been on the FDA’s drug shortage lists since 2011, in part due to a shutdown of a Luitpold facility. Fresenius Kabi launched 30 ml vials of the product in 2012.
According to the current FDA drug shortage list, 10 ml vials are still unavailable from Luitpold and from Roxane Laboratories.
Read the Fresenius Kabi press release.
